ࡱ> g bjbjVV nr<r< HHHHH\\\8\&`   %%%%%%%$(+H%uH"%HH  A&$$$H H %$%$$$ 0N F$%W&0&$+ !+$+H$$%%$&+ : Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limiteda joint stock company established in the People s Republic of China with limited liability Stock Code0719 UNAUDITED QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2017The board of directors (the Board) of Shandong Xinhua Pharmaceutical Company Limited (the Company) hereby announces the unaudited consolidated results of the Company and its subsidiaries (the Group) for the 9 months ended 30 September 2017. All financial information set out in this announcement has been prepared in accordance with the CASBE (as defined under the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited).This announcement was prepared in both Chinese and English. In the event of any inconsistencies between the two versions, the Chinese version shall prevail.1. KEY ACCOUNTING AND FINANCIAL DATAAs at 30 Sep 2017(Unaudited)RMB YuanAs at 31 Dec 2016(Audited)RMB YuanChangeTotal assets5,168,691,022.394,722,785,963.849.44%Net assets attributable to the shareholders of the Company2,204,574,772.001,988,419,824.3310.87%Jan - Sep 2017(Unaudited)RMB YuanJan - Sep 2016(Unaudited)RMB YuanChangeOperating income3,452,702,029.042,976,470,152.8016.00%Net profit attributable to the shareholders of the Company173,673,696.3889,180,216.4994.74%Net profit attributable to the shareholders of the Company after deduction of non-recurring profit and loss120,792,080.0978,516,685.8653.84%Net cash flow from operating activities193,925,949.01241,910,554.24(19.84%)Basic earnings per share (RMB Yuan / Share)0.380.2090.00%Diluted earnings per share (RMB Yuan / Share)0.380.2090.00%Ratio of weighted average return on net assets8.28%4.63%Increase by 3.65 percentage points2. PROFIT AND LOSS ACCOUNTItemsJan - Sep 2017Jan - Sep 2016ConsolidatedParent companyConsolidatedParent companyRMB YuanRMB YuanRMB YuanRMB Yuan(Unaudited)(Unaudited)(Unaudited)(Unaudited)1.Total operating income3,452,702,029.041,847,255,011.382,976,470,152.801,598,193,459.85Include: Operating income3,452,702,029.041,847,255,011.382,976,470,152.801,598,193,459.85 Interestincome---- Premium earned---- Service charge and commission fee----2. Total operating cost3,280,550,080.651,744,419,463.512,862,065,268.451,581,297,675.94Include: Operating cost2,516,331,423.211,387,023,169.592,257,191,811.681,278,423,003.35 Interest expense---0 Service charge and commission fee---0 Surrendervalue---0 Netpaymentsforinsuranceclaims---0 Netpaymentsfor withdrawal of insurance contract provisions---0 Policyholder dividend payment---0 Reinsurance expenses---0 Taxes and surcharges45,718,988.0627,567,287.9923,510,403.7312,434,415.03 Selling expenses373,449,730.6031,503,760.94291,511,775.3932,715,884.76 Administrative expenses291,923,674.13230,147,005.94243,053,222.88184,615,996.56 Financial expenses60,886,505.9659,320,209.0543,527,615.7144,737,303.67 Assets impairment loss(7,760,241.31)(1,068,037.72)3,270,439.062,736,091.86Plus: Change in fair value (losses to be listed with brackets)----Investment incomes (losses to be listed with brackets)5,781,567.639,926,067.727,781,048.8225,634,980.71 Include: Income from investment in associates and joint ventures----Exchange gains (losses to be listed with brackets)----Other income----3. Operating profit (losses to be listed with brackets)177,933,516.02122,687,683.31122,185,933.1768,165,745.33Plus: Non-operating income57,556,836.4051,184,287.2010,472,911.689,661,875.50 Include: Gains from disposal of non-current assets45,853,746.1339,744,729.992,072,356.001,923,228.05Less: Non-operating expenses7,321,002.165,042,423.739,065,314.924,309,779.76 Include: Loss from disposal of non-current assets1,218,192.70605,544.86991,151.25768,147.094. Total profit (losses to be listed with brackets)228,169,350.26168,829,546.78123,593,529.9373,517,841.07Less: income tax expenses45,228,494.3025,024,741.3524,452,937.607,348,434.615. Net profit (net losses to be listed with brackets)182,940,855.96143,804,805.4399,140,592.3366,169,406.46Net profit attributable to the equity holders of the parent company173,673,696.38-89,180,216.49-Minority interest income9,267,159.58-9,960,375.84-6. Net amount of other comprehensive income after tax42,645,762.5342,772,476.00(5,768,987.04)(6,825,051.20)Net amount of other comprehensive income after taxattributable to the owners of parent company 42,481,251.29-(6,041,743.11)-(I) Other comprehensive income not subject to reclassification to profit or loss subsequently ---- 1. Changes in net liabilities or net assets after re-measurement of defined benefit plans ---0 2.Share of other comprehensive income of the investees which cannot be reclassified to profit or loss underequity method ---- (II) Other comprehensive income to be reclassified to profit and loss subsequently 42,481,251.2942,772,476.00(6,041,743.11)(6,825,051.20) 1. Share of other comprehensive income of the investees which can be reclassified to profit or loss under equity method subsequently ---- 2. Profit and loss of change in fair value of financial assets available for sale 42,772,476.0042,772,476.00(6,825,051.20)(6,825,051.20) 3. Profit and loss of held-to-maturity investment reclassified to available-for-sale financial assets ---- 4. q r s t   v x z . 0 2 4 H J R T V Ĩ{j\V\L\V\@\LhkKHPJnHtHhkKHnHtH hkKHhkKHPJ^JnHtH hk5CJKH\aJnHtH$hk5CJKHPJ\aJnHtH2hkhk5CJKHOJPJQJ\aJnHtH6hkhk5CJKHOJPJQJ\^JaJnHtH%hk5B*CJKHOJ\aJph# jhkUmHnHtHuhkB*CJKHOJaJph# hk6KH]q r t u  x 2 V   jkgdq@m$gdq@ 00XDYD $00XDYDa$$00XDYDa$gdH$x07$8$H$XD2YDa$$007$8$H$XDYDa$ $7$8$H$a$7$8$H$V    $ _ f Yuƶp]J]:hIIB*CJOJPJaJph%hhB*CJOJPJaJph%hIIhIIB*CJOJPJaJph"hBsB*CJOJPJaJo(phhBsB*CJOJPJaJph"hBsB*CJOJPJaJo(ph"hk5B*CJOJPJaJphhkB*CJOJPJaJphhkB*OJPJnHphtH%hH5B*CJOJPJ\aJph+hHhH5B*CJOJPJ\aJph-jklȮn[F0+hq@hII5B*CJOJPJ\aJph(h-w5B*CJOJPJ\aJo(ph%hO#5B*CJOJPJ\aJph%h-w5B*CJOJPJ\aJph-hq@hkB*CJOJPJaJnHphtH+hq@hk5B*CJOJPJ\aJph3hq@hk5B*CJOJPJ\aJnHphtH'hkB*CJOJPJaJnHphtH%hU8hU8B*CJOJPJaJphhkB*CJOJPJaJphg~kd$$Ifl,\@ %5& `   t&644 laytQ$$Ifa$gd 8m$ $Ifgdq@m$ Xi辩辅rf[Prf[P:+hq@hk5B*CJOJPJ\aJphhq@h-wCJaJh-wh-wCJaJh-wh-w5CJaJ%hq@h-wB*CJOJPJaJphhq@hkCJaJ0hq@hkB*CJOJPJ\aJnHphtH(hq@hkB*CJOJPJ\aJph%hq@hkB*CJOJPJaJph-hq@hIIB*CJOJPJaJnHphtH-hq@hkB*CJOJPJaJnHphtHXizvk $Ifgdq@m$|kdu$$Ifl\@ %5& `   t&644 laytQ $$Ifa$gd"|qqqqqqqcq$$Ifa$gd 8m$ $Ifgdq@m$gdq@m$|kd$$Ifl\@ %5& `   t&644 laytQ λ}}g}R<#0hq@hkB*CJOJPJ\aJnHphtH*hO#B*CJOJPJ\aJnHphtH(hq@hkB*CJOJPJ\aJph+hq@hII5B*CJOJPJ\aJph+hq@hk5B*CJOJPJ\aJph%hO#5B*CJOJPJ\aJph(hfo5B*CJOJPJ\aJo(ph%hfo5B*CJOJPJ\aJph3hq@hk5B*CJOJPJ\aJnHphtH-hO#5B*CJOJPJ\aJnHphtHɴshUI<1&hq@hfoCJaJhfohfoCJaJhfohfoCJPJaJhfohfo5CJaJ%hq@hfoB*CJOJPJaJphhq@hkCJaJ%hq@hkB*CJOJPJaJph(hq@hIIB*CJOJPJ\aJph0hq@hkB*CJOJPJ\aJnHphtH(hq@hkB*CJOJPJ\aJph"hO#B*CJOJPJ\aJph%hfoB*CJOJPJ\aJo(ph"hfoB*CJOJPJ\aJphuiii $$Ifa$gdfo $Ifgdq@m$~kdc$$Ifl\| }%  j 3 t%644 laytQKZhowkkk $$Ifa$gdfo $IfgdUm$|kd$$Ifl\| }%  j 3 t%644 laytQKZhop)8GHNOPQ~ (/0123ȽȽӴȴȽȽȽӴȴȽv-hH5B*CJOJPJ\aJnHphtH+hq@hk5B*CJOJPJ\aJphhdTCJaJhQCJaJo(hdTCJaJo(hq@hfoCJaJhfohfoCJaJhfohfoCJPJaJhfohfo5CJaJ%hq@hfoB*CJOJPJaJph)opwkkk $$Ifa$gdfo $IfgdUm$|kdO$$Ifl\| }%  j 3 t%644 laytQ)8GPwkkk $$Ifa$gdfo $Ifgdq@m$|kd$$Ifl\| }%  j 3 t%644 laytQPQk~wwkkk $$Ifa$gdfo $Ifgdq@m$|kd=$$Ifl\| }%  j 3 t%644 laytQwwkkk $$Ifa$gdfo $Ifgdq@m$|kd$$Ifl\| }%  j 3 t%644 laytQ 0wkk]$$4$Ifa$gddT $$Ifa$gdfo $Ifgdvm$|kd+$$Ifl\| }%  j 3 t%644 laytQ0123NOUds||||n``$$1$Ifa$gdO#$$1$Ifa$gd"gdq@m$|kd$$Ifl\| }%  j 3 t%644 laytQ347OXYdghstcd~˵rrrraTaTaThg|h'CJPJaJ!hg|h'B*CJKHaJphhg|h'CJKHPJaJhO#CJKHaJhg|h'CJKHaJhO#5CJKH\aJhg|h'5CJKH\aJ+hq@hk5B*CJOJPJ\aJph3hq@hk5B*CJOJPJ\aJnHphtH3hq@hk5B*CJOJPJ\aJnHphtH sturrrrr$$1$Ifa$gd"kd$$Ifl4F 5&`G GHGJ tD&    44 lBa]pyt'PBBBBB$$1$Ifa$gd"kd$$Ifl4r 5&F GPGGG tD&44 lBa]p2yt'PBBBBB$$1$Ifa$gd"kd$$Ifl4r 5&F GPGGG tD&44 lBa]p2yt'0ARPB444$$1$Ifa$gd"$$1$Ifa$gd"kdm$$Ifl4Ir 5&F GPGGG tD&44 lBa]p2yt'Rcd"kdA$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'$$1$Ifa$gd"d~$$1$Ifa$gd"$$1$Ifa$gd"0"$$1$Ifa$gd"kdI $$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'$$1$Ifa$gd" 0"$$1$Ifa$gd"kdQ $$Iflr 5&G GPGGG  t2D&44 lBa]p2yt' /1DLMe'l|~0@BJL\^tv@|} h B*CJKHaJo(phhvCJKHaJhL2CJKHaJh'CJKHaJo(h'CJKHaJhg|h'CJPJaJ!hg|h'B*CJKHaJphhg|h'CJKHaJ= $$1$Ifa$gd"D0"$$1$Ifa$gd"kdY $$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'DFHJL$$1$Ifa$gd"LMe0"$$1$Ifa$gd"kda $$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'ev$$1$Ifa$gd"0"$$1$Ifa$gd"kdi$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'$$1$Ifa$gd"'0"$$1$Ifa$gd"kdq$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'')+-$$1$Ifa$gd"l0"$$1$Ifa$gd"kdy$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'lptx|$$1$Ifa$gd"|~0"$$1$Ifa$gd"kd$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'$$1$Ifa$gd"00"$$1$Ifa$gd"kd$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'048<@$$1$Ifa$gd"@B0"$$1$Ifa$gd"kd$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'$$1$Ifa$gd"L0"$$1$Ifa$gdL2kd$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'LPTX\$$1$Ifa$gd"\^0"$$1$Ifa$gd"kd$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'$$1$Ifa$gd"0"$$1$Ifa$gdL2kd$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt' <Xt$$1$Ifa$gd"tv0"$$1$Ifa$gd"kd$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt' $$1$Ifa$gd"@0"$$1$Ifa$gd"kd$$Ifl+r 5&G GPGGG  t2D&44 lBa]p2yt'@O^m|$$1$Ifa$gd"|}0"$$1$Ifa$gd"kd$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'$$1$Ifa$gd"0"$$1$Ifa$gd"kd$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'*7$$1$Ifa$gd"78<>ISlmtuvw89ABKQkrstu}Ȼһxһkһah6bCJKHaJhvhvCJKHaJhVCJKHaJh ^CJKHaJhU7DhU7DCJKHaJhU7DCJKHaJo(hVhVCJKHaJhvCJKHaJhg|h'CJKHaJhL2CJKHaJhg|h'CJPJaJ!hg|h'B*CJKHaJphh B*CJKHaJo(ph&78w0"$$1$Ifa$gdvkd$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'wy{}$$1$Ifa$gd"0"$$1$Ifa$gd"kd$$Ifltr 5&G GPGGG  t2D&44 lBa]p2yt'$$1$Ifa$gd"90"$$1$Ifa$gdvkd$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'9;=?A$$1$Ifa$gd"ABu0"$$1$Ifa$gd6bkd$$Ifltr 5&G GPGGG  t2D&44 lBa]p2yt'uwy{}$$1$Ifa$gd"}~0"$$1$Ifa$gd"kd$$Iflr 5&g GPGGG  t2D&44 lBa]p2yt'}~ $[\!"]MN[\]ayz˾˾˾~hCJKHaJh6bCJKHaJhL2CJKHaJh ^CJKHaJhU7DhU7DCJKHaJhU7DCJKHaJo(hVhVCJKHaJhVCJKHaJ!hg|h'B*CJKHaJphhg|h'CJKHaJhg|h'CJPJaJ1$$1$Ifa$gd"0"$$1$Ifa$gdUkd$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'$$1$Ifa$gd" $0"$$1$Ifa$gd"kd!$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'$2@N[$$1$Ifa$gd"[\0"$$1$Ifa$gd"kd"$$Ifl+r 5&G GPGGG  t2D&44 lBa]p2yt'$$1$Ifa$gd"0"$$1$Ifa$gd"kd#$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'!$$1$Ifa$gd"!"]0"$$1$Ifa$gd"kd$$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt']ju$$1$Ifa$gd"0"$$1$Ifa$gd6bkd'%$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'$$1$Ifa$gd"0"$$1$Ifa$gd"kd/&$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'$2@M$$1$Ifa$gd"MN0"$$1$Ifa$gd6bkd7'$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt' $ % 6 = > \ ] ` -!.!/!?!@!L!M!P!Q!U!!!!!!!!˾˾ܴ˾ܧ˗˗˾˗˗˾ܧ˾|ohg|hHfCJKHaJhHfCJKHaJ!hg|h B*CJKHaJphh B*CJKHaJo(phhHfhHfCJKHaJh6bCJKHaJhg|h'CJPJaJ!hg|h'B*CJKHaJphhg|h'CJKHaJhVhVCJKHaJh ^CJKHaJ+$$1$Ifa$gd" 0"$$1$Ifa$gd"kd?($$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'   " $ $$1$Ifa$gd"$ % > 0"$$1$Ifa$gd"kdG)$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'> K M Z \ $$1$Ifa$gd"\ ] 0"$$1$Ifa$gd"kdO*$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt' $$1$Ifa$gd $$1$Ifa$gd" !/!0""$$1$Ifa$gdHfkdW+$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'/!=!?!N!P!$$1$Ifa$gd"P!Q!!0"$$1$Ifa$gd"kd_,$$Ifltr 5&G GPGGG  t2D&44 lBa]p2yt'!!!!!$$1$Ifa$gd"!!F"0"$$1$Ifa$gdHfkdg-$$Ifltr 5&G GPGGG  t2D&44 lBa]p2yt'!F"V"X""h#l#|#~#$$$0$1$=$>$?$@$L$M$N$O$W$X$$$$$$$;%=%Y%Z%f%g%h%i%u%v%w%x%{%|%%%%%%% 3 4 < = y z    󮗮!hg|h B*CJKHaJphUhHfh B*CJKHaJo(phhHfCJKHaJhHfhHfCJKHaJhg|h'CJPJaJ!hg|h'B*CJKHaJphhg|h'CJKHaJ;F"J"N"R"V"$$1$Ifa$gd"V"X"N#l#0""$$1$Ifa$gdHfkdo.$$Ifldr 5&G GPGGG  t2D&44 lBa]p2yt'l#p#t#x#|#$$1$Ifa$gd"|#~#$0"$$1$Ifa$gdUkdw/$$Ifl&r 5&G GPGGG  t2D&44 lBa]p2yt'$"$0$?$N$$$1$Ifa$gd"N$O$$0"$$1$Ifa$gd"kd0$$Ifltr 5&G GPGGG  t2D&44 lBa]p2yt'$$$$$$$1$Ifa$gd"$$=%0"$$1$Ifa$gd"kd1$$Ifl&r 5&G GPGGG  t2D&44 lBa]p2yt'=%K%Y%h%w%$$1$Ifa$gd"w%x%%0"$$1$Ifa$gd"kd2$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'%%%%%$$1$Ifa$gd"%%4 0"$$1$Ifa$gd"kd3$$Ifldr 5&G GPGGG  t2D&44 lBa]p2yt'Effective part of cash flow hedging profit and loss---- 5.Conversion difference of foreign currency statement(291,224.71)-783,308.09- 6. Others----Net amount of other consolidated income after tax attributableto the minority shareholders164,511.24-272,756.07-7. Total comprehensive income225,586,618.49186,577,281.4393,371,605.2959,344,355.26Total comprehensive income attributable to the shareholders of parent company216,154,947.67-83,138,473.38-Total comprehensive income attributable to the minority shareholders9,431,670.82-10,233,131.91-8. Earnings per share:(I) Basic earnings per share (RMB Yuan / Share)0.38-0.2-(II) Diluted earnings per share(RMB Yuan / Share)0.38-0.2-By order of the Board of DirectorsShandong Xinhua Pharmaceutical Company Limited Zhang Daiming Chairman30 October 2017, Zibo, PRCAs at the date of this announcement, the Board comprises: Executive Directors:Mr. Zhang Daiming (Chairman)Mr. Du DepingIndependent Non-executive Directors:Mr. Du GuanhuaMr. Li WenmingMr. Chan Chung Kik, LewisNon-executive Directors: Mr. Ren FulongMr. Xu Lie Mr. Zhao BinPAGE 54 6 8 : < $$1$Ifa$gd"< = y 0"$$1$Ifa$gd"kd4$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'y     $$1$Ifa$gd"$$1$Ifa$gd    0"$$1$Ifa$gd"kd5$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'      %&~STopBzgR(hhk5B*CJOJPJaJph%hhB*CJOJPJaJphhkB*CJOJPJaJph3hq@hk5B*CJOJPJ\aJnHphtHhg|h'CJKHPJaJ!hg|h'B*CJKHaJph!h>Yh>YB*CJKHaJph!hg|h'B*CJKHaJphhg|h'CJKHaJhg|h'CJPJaJ     $$1$Ifa$gd"    0""$$1$Ifa$gd>Ykd6$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt' #%$$1$Ifa$gd"%&D0"$$1$Ifa$gd"kd7$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'DSbp~$$1$Ifa$gd"~0"$$1$Ifa$gd"kd8$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'$$1$Ifa$gd"40"$$1$Ifa$gd"kd9$$Ifl r 5&G GPGGG  t2D&44 lBa]p2yt'4ACQS$$1$Ifa$gd"STkl0""$$1$Ifa$gd"kd:$$Ifl r 5&G GPGGG  t2D&44 lBa]p2yt'lmnopC5$$1$Ifa$gd"kd;$$Ifl;r 5&f fPfff tD&44 lBa]p2yt'$$1$Ifa$gd"$$1$Ifa$gd"0"$$1$Ifa$gd"kd<$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'$$1$Ifa$gd"0+"$]a$gd'kd=$$Iflr 5&G GPGGG  t2D&44 lBa]p2yt'B+HVW| $$Ifa$ $7$8$H$If$a$|]|$|]|a$$]a$|WD ]|`gdBjtu|缨vfvR@<@<@<@<hk#hkB*CJKHOJPJaJph'hkB*CJOJPJaJnHphtHhB*CJOJPJaJph"hB*CJOJPJaJo(phhB*CJOJPJaJphhkB*CJOJPJaJph'hkB*CJOJPJaJnHphtH(hhk5B*CJOJPJaJph*h5B*CJOJPJaJnHphtH0hhk5B*CJOJPJaJnHphtHOI|]|Nkd>$$If0!644 a $7$8$H$If $$Ifa$Nkd>$$If0!644 ahkh6t0JmHnHu hk0Jjhk0JUhVjhVUhkB*ph|]|&`=0P&P 1. A!"#$% Dpnu*l?xK-PNG  IHDRryJzgAMA pHYsLLXtcPLTE#$ 84*&'"51;7.*?;2-2./+40)%(#,(=9950,+'=83.627383B>B?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCB6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~PJ_HmH nHsH tHR`R Normal $1$a$ CJKH_HaJmH nHsH tHD@D  Heading 1$@&CJPJnHtHDA`D Default Paragraph FontVi@V 0 Table Normal :V 44 la (k (0No List hoh Default1$7$8$H$1B*CJOJPJ^J_HaJmH nHphsH tH,O, CM1 B*ph,O, CM2 B*ph,O, CM4 B*ph,O, CM5 B*ph2O2 CM3d B*ph4R4 L20HeaderB#R>@R Title$$$dBTJa$5CJ KH \aJ FoqF  Title Char5CJ OJQJ\^JaJ D @D Footer$9r G$a$CJaJ:o:  Footer Char CJ^JaJ2)`2  Page Number^J<@<  Balloon TextCJaJFoF Balloon Text Char CJ^JaJnOnChar Char Char Char$d1$a$CJKHaJmHnHuo Leading 12+$TQd1$7$8$H$a$(CJ OJPJQJ_HaJ mH nHsH tHJoJ L20 Header CharCJKHaJmH nHsH tHB'B 6t0Comment ReferenceCJaJ<@< "6t0 Comment Text!CJaJN/!N !6t0Comment Text CharKHmH nHsH tH@j@@ $6t0Comment Subject#5\Z/AZ #6t0Comment Subject Char5KH\mH nHsH tHPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7fW+Ն7`g ȘJj|h(KD-dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJuV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbeSd̛\17 pa>SR!3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fvu"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK!ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э56?$Q,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-!ѐ' theme/theme/_rels/themeManager.xml.relsPK] D V 3}! B&0PZkxoP0sRd DLe'l|0@L\t@|7w9Au}$[!]M $ > \ /!P!!!F"V"l#|#$N$$$=%w%%%4 < y     %D~4Sl !"#$%'()*+,-./123456789:;<=>?@ABCDEFGHIJKLMNOQRSTUVWXY[\]^_`abcdefghijlmnopqrstuvwyz{|}~ !t ,b$l?xK-}*?D@H 0(  (  V  3 A?#" ?B S  ?r6tuvvww>> %@J,8HJQv4Fu 7 8 ` a   { |  : B \]z{!Y 6o;qr-b&`5pRZI`})*Ba4AtI65IU8V6tl "O# '&.L2 8>>q@U7D9OdT>YlY ^ofoYsTttv-w<6b ~k'XbBsUQVH1HX5>UIIHf|a:F}*'@puu @ @4@"H@@Unknown G*Ax Times New Roman5Symbol3. *Cx ArialE(SimSun?????M (PMingLiU!Ps2OcuAegPMCHM I+ TimesArial Unicode MS7@Cambria3*Ax TimesA$BCambria Math"hdTg%Z$Z|i&5i&5ixr KQHP  $Po2 xx vvvvvv CharltonsOh+'0p   , 8DPX`hvvvvvv Normal.dotm Charltons29Microsoft Office Word@R@͝N@P"f@^Ni&՜.+,0  hp   x6x8.com5  Title標題  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry FpNData 1?1Table+WordDocument nSummaryInformation(DocumentSummaryInformation8MsoDataStoreLN0NCJ4CKEFF0X5==2LN0NItem  PropertiesUCompObj r   F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q